GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1176 - 1200 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 2 15 mild
G00065MO
75
IgM Patient 1 6 moderate
G67045LB
75
IgM Patient 2 24 mild
G84224TW
75
IgM Patient 2 3 mild
G41200QS
75
IgG Patient 3 -180 mild
G32611KT
75
IgM Patient 3 -180 mild
G00054MO
75
IgG Patient 4 12 mild
G29011JC
75
IgG Patient 4 12 mild
G32611KT
75
IgG Patient 4 12 mild
G37383BH
75
IgG Patient 1 10 moderate
G60761LT
76
IgG Patient 1 10 moderate
G96865DJ
76
IgG Patient 3 4 mild
G03499BP
76
IgG Patient 3 4 mild
G91537AT
76
IgM Patient 3 11 mild
G29857RC
76
IgM Patient 3 11 mild
G52880ZN
76
IgG Patient 4 12 mild
G08520NM
76
IgM Patient 1 22 moderate
G32611KT
77
IgG Patient 2 3 mild
G53168IY
77
IgG Patient 3 11 mild
G39023AU
77
IgG Patient 3 11 mild
G61399NC
77
IgG Patient 3 11 mild
G91537AT
77
IgG Patient 3 4 mild
G39023AU
77
IgG Patient 3 4 mild
G65889KE
77
IgM Patient 3 4 mild
G21460SG
77
IgG Patient 4 12 mild
G24617OK
77

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024